Biotech Stock Roundup: XenoPort Soars on Acquisition Deal, AbbVie Crohn's Disease Drug Fares Well
Acquisitions and deals are picking up pace in the biotech sector with quite a few announcements being made over the last few days. XenoPort (XNPT - Snapshot Report) agreed to be acquired by Arbor Pharmaceuticals and saw its shares shoot up on the ...